Promoter analysis of human glutamate carboxypeptidase II

Brain Research

Volumn 1170, Issue SUPPL.: COMPLETE, 2007, Pages 1-12

  Han, Liqun ^a   Lee Wong, Dona ^a   Tsai, Guochuan ^b   Jiang, Zhichun ^b   Coyle, Joseph T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Glutamate carboxypeptidase II; Lymphoid transcription factor 1 (LyF 1); Promoter; Prostate specific membrane antigen; Regulation of gene transcription; Schizophrenia

Indexed keywords

DNA FRAGMENT; GLUTAMATE CARBOXYPEPTIDASE II; LUCIFERASE;

5' UNTRANSLATED REGION; ARTICLE; ASTROCYTE; CELL STRAIN LNCAP; GENE CONTROL; GENE DELETION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; REPORTER GENE; SCHIZOPHRENIA; SITE DIRECTED MUTAGENESIS; TATA BOX; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

5' UNTRANSLATED REGIONS; ANTIGENS, SURFACE; BASE SEQUENCE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, REPORTER; GENETIC VECTORS; GLUTAMATE CARBOXYPEPTIDASE II; HELA CELLS; HUMANS; IKAROS TRANSCRIPTION FACTOR; LUCIFERASES; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PLASMIDS; PROMOTER REGIONS, GENETIC; RNA; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

MAMMALIA;

EID: 34548472182     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.07.017     Document Type: Article

References (40)

1. Bacich D.J., Pinto J.T., and Heston W.P. Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase. Mamm. Genome 12 (2001) 117-123
2. Blake M.C., and Azizkhan J.C. Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol. Cell. Biol. 9 (1989) 4994-5002
3. Berger U.V., Luthi-Carter R., Passani L.A., Elkabes S., Black I., Konradi C., and Coyle J.T. Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J. Comp. Neurol. 415 (1999) 52-64
4. Bergeron R., Coyle J.T., Tsai G., and Greene R.W. NAAG reduces NMDA receptor current in CA1 hippocampal pyramidal neurons of acute slices and dissociated neurons. Neuropsychopharmacology 30 (2005) 7-16
5. Blakely R.D., Robinson M.B., and Thompson R.C. Hydrolysis of the brain dipeptide N-acetyl-l-aspartyl-l-glutamate: subcellular and regional distribution, ontogeny, and the effect of lesions on N-acetylated-alpha-linked acidic dipeptidase activity. J. Neurochem. 50 (1988) 1200-1209
6. Burger M.J., Tebay M.A., Keith P.A., Samaratunga H.M., Clements J., Lavin M.F., and Gardiner R.A. Expression analysis of delta-catenin and prostate-specific membrane antigen: their potential as diagnostic markers for prostate cancer. Int. J. Cancer 100 2 (2002) 228-237 (Jul 10)
7. Chen B.T., Loberg R.D., Neeley C.K., O'Hara S.M., Gross S., Doyle G., Dunn R.L., Kalikin L.M., and Pienta K.J. Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease. Urology 65 (2005) 616-621
8. Coyle J.T. Substance use disorders and Schizophrenia: a question of shared glutamatergic mechanisms. Neurotox. Res. 10 (2006) 221-233
9. Flores C., and Coyle J.T. Regulation of glutamate carboxypeptidase II function in corticolimbic regions of rat brain by phencyclidine, haloperidol, and clozapine. Neuropsychopharmacology 28 (2003) 1227-1234
10. Goff D.C., Bottiglieri T., Arning E., Shih V., Freudenreich O., Evins A.E., Henderson D.C., Baer L., and Coyle J. Folate, homocysteine, and negative symptoms in schizophrenia. Am. J. Psychiatry 161 (2004) 1705-1708
11. Good D., Schwarzenberger P., Eastham J.A., Rhoads R.E., Hunt J.D., Collins M., Theodossiou M., Kolls C., and Grimes J.K. Cloning and characterization of the prostate-specific membrane antigen promoter. J. Cell. Biochem. 74 (1999) 395-405
12. Ghose S., Weickert C.S., Colvin S.M., Coyle J.T., Herman M.M., Hyde T.M., and Kleinman J.E. Glutamate carboxypeptidase II gene expression in the human frontal and temporal lobe in schizophrenia. Neuropsychopharmacology 29 (2004) 117-125
13. Grunze H.C., Rainnie D.G., Hasselmo M.E., Barkai E., Hearn E.F., McCarley R.W., and Greene R.W. NMDA-dependent modulation of CA1 local circuit inhibition. J. Neurosci. 16 (1996) 2034-2043
14. Hahm K., Ernst P., Lo K., Kim G.S., Turck C., and Smale S.T. The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol. Cell. Biol. 14 (1994) 7111-7123
15. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4746-4751
16. Halsted C.H., Ling E.H., Luthi-Carter R., Villanueva J.A., Gardner J.M., and Coyle J.T. Folylpoly-gamma-glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II. J. Biol. Chem. 273 (1998) 20417-20424
17. Israeli R.S., Powell C.T., Fair W.R., and Heston W.D. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res. 53 (1993) 227-230
18. Israeli R.S., Powell C.T., Corr J.G., Fair W.R., and Heston W.D. Expression of the prostate-specific membrane antigen. Cancer Res. 54 (1994) 1807-1811
19. Kawai Y., Asai K., Miura Y., Inoue Y., Yamamoto M., Moriyama A., Yamamoto N., and Kato T. Structure and promoter activity of the human glia maturation factor-gamma gene: a TATA-less, GC-rich and bidirectional promoter. Biochim. Biophys. Acta 1625 (2003) 246-252
20. Lennon A.M., Ottone C., Rigaud G., Deaven L.L., Longmire J., Fellous M., Bono R., and Alcaide-Loridan C. Isolation of a B-cell-specific promoter for the human class II transactivator. Immunogenetics 45 (1997) 266-273
21. Lo K., Landau N.R., and Smale S.T. LyF-1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte-specific genes. Mol. Cell. Biol. 11 (1991) 5229-5243
22. Luthi-Carter R., Berger U.V., Barczak A.K., Enna M., and Coyle J.T. Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 3215-3220
23. Masumoto N., Chen J., and Sirotnak F.M. Regulation of transcription of the murine gamma-glutamyl hydrolase gene. Delineation of core promoter A and the role of LYF-1, E2F and ETS-1 in determining tumor-specific expression. Gene 291 (2002) 169-176
24. Meyerhoff J.L., Bobinson M.B., Bixler M.A., Richards S.S., and Coyle J.T. Seizures decrease regional enzymatic hydrolysis of N-acetyl-aspartylglutamate in rat brain. Brain Res. 505 (1989) 130-134
25. Mitsiades C.S., Lembessis P., Sourla A., Milathianakis C., Tsintavis A., and Koutsilieris M. Molecular staging by RT-pCR analysis for PSA and PSMA in peripheral blood and bone marrow samples is an independent predictor of time to biochemical failure following radical prostatectomy for clinically localized prostate cancer. Clin. Exp. Metastasis 21 (2004) 495-505
26. Molnar A., and Georgopoulos K. The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol. Cell. Biol. 14 (1994) 8292-8303
27. Neale J.H., Bzdega T., and Wroblewska B. N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J. Neurochem. 75 (2000) 443-452
28. O'Keefe D.S., Su S.L., Bacich D.J., Horiguchi Y., Luo Y., Powell C.T., Zandvliet D., Russell P.J., Molloy P.L., Nowak N.J., Shows T.B., Mullins C., Vonder Haar R.A., and Fair W.R. Mapping, genomicorganization and promoter analysis of the human prostate-specific membrane antigen gene. Biochim. Biophys. Acta 1443 (1998) 113-127
29. Papadopoulou E., Davilas E., Sotiriou V., Georgakopoulos E., Georgakopoulou S., Koliopanos A., Aggelakis F., Dardoufas K., Agnanti N.J., Karydas I., and Nasioulas G. Cell-free DNA and RNA in plasma as a new molecular marker for prostate and breast cancer. Ann. N.Y. Acad. Sci. 1075 (2006) 235-243
30. Payne K.J., Huang G., Sahakian E., Zhu J.Y., Barteneva N.S., Barsky L.W., Payne M.A., and Crooks G.M. Ikaros isoform x is selectively expressed in myeloid differentiation. J. Immunol. 170 (2003) 3091-3098
31. Picker J.D., and Coyle J.T. Do maternal folate and homocysteine levels play a role in neurodevelopmental processes that increase risk for schizophrenia? vol. 13 (2005) 197-205
32. Pinto J.T., Suffoletto B.P., Berzin T.M., Qiao C.H., Lin S., Tong W.P., May F., Mukherjee B., and Heston W.D. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. Clin. Cancer Res. 2 (1996) 1445-1451
33. Robinson M.B., Blakely R.D., and Coyle J.T. Quisqualate selectively inhibits a brain peptidase which cleaves N-acetyl-l-aspartyl-l-glutamate in vitro. Eur. J. Pharmacol. 130 (1986) 345-347
34. Sacha P., Zamecnik J., Barinka C., Hlouchova K., Vicha A., Mlcochova P., Hilgert I., Eckschlager T., and Konvalinka J. Expression of glutamate carboxypeptidase II in human brain. Neuroscience 144 (2007) 1361-1372
35. Sekiguchi M., Okamoto K., and Sakai Y. Low-concentration N-acetylaspartylglutamate suppresses the climbing fiber response of Purkinje cells in guinea pig cerebellar slices and the responses to excitatory amino acids of Xenopus laevis oocytes injected with cerebellar mRNA. Brain Res. 482 (1989) 87-96
36. Slusher B.S., Tsai G., Yoo G., and Coyle J.T. Immunocytochemical localization of the N-acetyl-aspartyl-glutamate (NAAG) hydrolyzing enzyme N-acetylated alpha-linked acidic dipeptidase (NAALADase). J. Comp. Neurol. 315 (1992) 217-229
37. Sun L., Liu A., and Georgopoulos K. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J. 15 (1996) 5358-5369
38. Tsai G., Passani L.A., Slusher B.S., Carter R., Baer L., Kleinman J.E., and Coyle J.T. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch. Gen. Psychiatry 52 (1995) 829-836
39. Watt F., Martorana A., Brookes D.E., Ho T., Kingsley E., O'Keefe D.S., Russell P.J., Heston W.D., and Molloy P.L. A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1. Genomics 73 (2001) 243-254
40. Wroblewska B., Wroblewski J.T., Pshenichkin S., Surin A., Sullivan S.E., and Neale J.H. N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J. Neurochem. 69 (1997) 174-181